Please ensure Javascript is enabled for purposes of website accessibility

2 Green Flags in Intuitive Surgical's Q4 Earnings

By Cory Renauer - Feb 6, 2021 at 6:59AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Despite a tough year, there were two big sources of encouragement from the surgical robotics leader.

While the coronavirus pandemic reminded us about the importance of healthcare, some businesses have been busier than others. Hospitals overrun with COVID-19 patients have been rescheduling non-emergency surgeries left and right, which hasn't been good for Intuitive Surgical (ISRG 2.69%)

Despite a troubling outlook for 2021, there were some highlights in Intuitive Surgical's latest earnings call. In this Motley Fool Live video recorded on Jan. 29, healthcare and cannabis bureau chief Corinne Cardina and writer Cory Renauer discuss two green flags in the company's latest earnings report.

Corinne Cardina: Let's talk about Intuitive Surgical. I think they reported on Friday of last week, so a week ago. What are two green flags from Intuitive Surgical's earnings?

Cory Renauer: OK. Intuitive Surgical reported 6% year-over-year procedure growth, which isn't as rapid as Intuitive Surgical's investors are used to. But I still think this is a green flag because, at the beginning of the pandemic, I didn't think Intuitive Surgical was going to report anything less than shrinking procedure volumes. I thought procedure volumes were going to just fall off a cliff this year, because like Johnson & Johnson's medical devices, Intuitive Surgical does those minimal invasive surgeries that are not emergency, they can be put off technically. So 6% procedure growth is impressive.

Cardina: It is. Is there a second green flag?

Renauer: Yes, second green flag for Intuitive Surgical's earnings, despite the pandemic, the company grew its bottom line without reducing spending on research and development or letting go of valuable employees. In the fourth quarter, the company reported adjusted earnings that actually grew about 4% year over year. So on the bottom line, the company actually made a little bit more money this year even though the coronavirus pandemic is about the worst thing you can imagine happening to a company like Intuitive Surgical.

Cardina: Yeah, it's really resilient. I think a lot of us probably were surprised by that. Intuitive Surgical is not as diversified as a company like Johnson & Johnson. It really depends on things happening in hospitals to do that. Most of its revenue is either from its systems or from the components of the system that you replace after using its products in surgery. Naturally, that fell but it was nice to see that the company is certainly not floundering by any means.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Intuitive Surgical, Inc. Stock Quote
Intuitive Surgical, Inc.
$206.10 (2.69%) $5.39
Johnson & Johnson Stock Quote
Johnson & Johnson
$179.52 (1.13%) $2.01

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/02/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.